BOSTON--(BUSINESS WIRE)--Ancora Heart, Inc., a company developing a completely transcatheter device-based therapy to address heart failure (HF), today announced that patients treated with the ...

In a recent study published in the journal Nature, a large team of researchers from the United States (U.S.) used single-cell ribonucleic acid (RNA) sequencing combined with high-resolution ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The heart is the central organ of the human circulatory system. Both congenital and acquired structural ...

People who live close to airports and are exposed to high aircraft noise levels could be at greater risk of poor heart function, increasing the likelihood of heart attacks, life-threatening heart ...

Congenital heart disease refers to heart defects that are present from birth, affecting the structure and function of the ...

Heart disease often develops quietly over many years before serious symptoms appear. By the time a person feels chest pain, shortness of breath, or fatigue, damage may already be widespread.

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...